Study finds benefits listed in larger text than risks in mags

Share this article:
A study of oncology drug ads in the magazines CURE, Coping With Cancer and MAMM found benefits presented more prominently and in larger text than risks. The study, presented to the American Society of Clinical Oncology's annual meeting, found that while benefits usually placed in the top third of the ad space, risks were often presented in smaller type and relegated to the lower half of the page.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.